NCT05420207Completed
Implantable Long-Acting Pre-Exposure Prophylaxis For MSM
Implantable Long-Acting Pre-Exposure Prophylaxis for HIV Prevention With MSM: A Qualitative Study of Patient and Physician Perspectives
Source: ClinicalTrials.gov · Last updated 24 Oct 2025
Brief summary (registry, in English)
The long-term goal of this project is to better understand factors at the patient and physician level that can be addressed to impact uptake of long-acting, implantable PrEP (LA-PrEP) products in the future and identify the training needs of physicians. This project specifically focuses on men who have sex with men (MSM) seen in primary care settings in Texas. The main objective of this project is to examine perspectives of MSM and physicians in Texas regarding LA-PrEP, including attitudes and barriers to use and implementation by interviewing patients and physicians from the same clinical practices.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 69 (actual)
- First submitted
- 10 Jun 2022
- Start date
- 14 Jun 2024
- Primary completion date
- 5 Sept 2025
- Lead sponsor
- Elizabeth Arnold
- Diseases
- HIV
- NCT number
- NCT05420207
What you commit to
- Study type: Observational
- Participants enrolled: 69
- From 14 Jun 2024 to the primary completion date, 5 Sept 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Those individuals who speak a language other than English or Spanish will be excluded as well as those who present with a cognitive or other impairment that would prevent them for consenting to participate in the study.
Who the study is looking for
- Patients must meet the following criteria:
- be a patient of one of the practices where physicians have agreed to participate or have been seen for a primary care visit in the past 12 months in the Dallas Austin, or San Antonio metro areas;
- be aged 18-45;
- be assigned male sex at birth and report having one or more male sexual partners in the past year; and
- be HIV negative.
- Physicians who are interested in participating must be a practicing primary care physician in the Dallas, San Antonio, or Austin metropolitan area and be willing to allow recruitment of patient participants from their practice.
Age in the registry: 18 years to 45 years · Sex: Male · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dell Medical School, UT Austin Coordinator of this site? Confirm its status | Austin | United States | Unknown status |
| University of Pittsburgh Coordinator of this site? Confirm its status | Pittsburgh | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.